Literature DB >> 6732240

Gossypol inhibition of adenylate cyclase.

K L Olgiati, D G Toscano, W M Atkins, W A Toscano.   

Abstract

Gossypol, a polyphenolic binaphthalene -dialdehyde reputed to exert contraceptive action in males, reversibly inhibits adenylate cyclase [ATP pyrophosphate lyase (cyclizing), EC 4.6.1.1] in a concentration-dependent manner. In membranes prepared from a variety of organs, the half-maximal inhibitory concentration (IC50) ranges from 75 microM (rat Leydig tumor cells) to 250 microM (rat liver membranes). Kinetic studies using partially purified catalytic subunit isolated from bovine testis show that gossypol is competitive with ATP with an apparent Ki of 110 microM. These data suggest that gossypol inhibition of adenylate cyclase is due to direct interaction at the nucleotide-binding domain of the catalytic subunit of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6732240     DOI: 10.1016/0003-9861(84)90404-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

Review 1.  Chemotherapeutic approaches for targeting cell death pathways.

Authors:  M Stacey Ricci; Wei-Xing Zong
Journal:  Oncologist       Date:  2006-04

2.  Gossypol increases expression of the pro-apoptotic BH3-only protein NOXA through a novel mechanism involving phospholipase A2, cytoplasmic calcium, and endoplasmic reticulum stress.

Authors:  Ryan S Soderquist; Alexey V Danilov; Alan Eastman
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

3.  Induction of neutrophil Mac-1 integrin expression and superoxide production by the medicinal plant extract gossypol.

Authors:  P Benhaim; S J Mathes; T K Hunt; H Scheuenstuhl; C C Benz
Journal:  Inflammation       Date:  1994-10       Impact factor: 4.092

4.  Gossypol effects on cultured normal and malignant melanocytes.

Authors:  F Hu; K Mah; D J Teramura
Journal:  In Vitro Cell Dev Biol       Date:  1986-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.